Biopharmaceutical company Alvotech announced today that Japan-based Fuji Pharma has acquired a 4.2 percent stake in the business for approximately $50 million. Alvotech and Fuji Pharma recently announced an exclusive agreement for development and commercialization of biosimilars in Japan. Key shareholders in Alvotech now are Aztiq Pharma AB, which is the controlling shareholder led by…